C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2009
12/31/2009	US20090325864 Novel protein and process for preparing the same
12/31/2009	US20090325815 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
12/31/2009	US20090325236 Optical sorting method
12/31/2009	US20090325231 Thermostable l-ribose isomerase and method for producing same and use of same
12/31/2009	US20090325230 Protein expression systems
12/31/2009	US20090325229 Process for Globular Adiponectin Production
12/31/2009	US20090325228 Fungal cell wall synthesis gene
12/31/2009	US20090325227 C-terminus modification method, c-terminus immobilization method and analysis method for protein or peptide
12/31/2009	US20090325226 Methods and Compositions for Producing Active Vitamin K-Dependent Proteins
12/31/2009	US20090325155 Aureobasin a synthetase
12/31/2009	US20090324634 Trypanosoma Antigens, Vaccine Compositions, and Related Methods
12/31/2009	US20090324627 ISOLATED DNA DIRECTED 50kD REGULATORY SUBUNIT (POLD2) GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM CHOMOSOME 7 AND THEIR USES
12/31/2009	US20090324626 Isolated snare ykt6 genomic polynucleotide fragments from chomosome 7 and their uses
12/31/2009	US20090324621 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
12/31/2009	US20090324608 Novel human protein kinase, phosphatase, and protease family members and uses thereof
12/31/2009	US20090324603 Met fab and scfv fragments and methods of use
12/31/2009	US20090324601 Targeted binding agents directed to pdgfr-alpha and uses thereof
12/31/2009	US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity
12/31/2009	US20090324597 Unique long 16 (UL-16)-binding proteins (ULBP) specific immunoglobulin for use in diganosis cell proliferative disorders
12/31/2009	US20090324592 Compositions and methods for the diagnosis and treatment of tumor
12/31/2009	US20090324590 Myostatin antagonists
12/31/2009	US20090324589 Methods for controlling blood pharmacokinetics of antibodies
12/31/2009	US20090324574 Esterases and Related Nucleic Acids and Methods
12/31/2009	US20090324562 Defensin Proteins
12/31/2009	US20090324538 Fusion molecules and IL-15 variants
12/31/2009	US20090324490 Compositions and methods for the diagnosis and treatment of tumor
12/30/2009	WO2009158511A1 Factor viii muteins with reduced immunogenicity
12/30/2009	WO2009157926A1 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof
12/30/2009	WO2009157746A1 Use of viral multimeric proteins as templates for construction of nanobiomaterials
12/30/2009	WO2009155842A1 Fusion protein of onconase and toxin transmembrane domain and preparation method and use thereof
12/30/2009	WO2009139853A3 Human monoclonal antibodies against human chemokine receptor ccr7
12/30/2009	WO2009134899A3 Producing biofuels using polyketide synthases
12/30/2009	WO2009132286A3 Regulating the production of isoprenoids in algal cells
12/30/2009	WO2009131919A3 Polymerases for incorporating modified nucleotides
12/30/2009	WO2009124294A3 Pharmaceutical compositions for binding sphingosine-1-phosphate
12/30/2009	WO2009120611A3 Aldehyde tags, uses thereof in site-specific protein modification
12/30/2009	WO2009116983A3 Compositions and methods for treating ebola virus infection
12/30/2009	WO2009100309A3 Anti-ifnar1 antibodies with reduced fc ligand affinity
12/30/2009	WO2009088805A3 Antibody targeting through a modular recognition domain
12/30/2009	WO2009085135A3 Yeast strains for protein production
12/30/2009	WO2009062112A3 Use of tam receptor inhibitors as antimicrobials
12/30/2009	WO2009058379A3 Protein scaffolds
12/30/2009	WO2009049284A3 Compositions and methods for improved glycoprotein sialylation
12/30/2009	WO2009048980A3 Emp2 antibodies and their therapeutic uses
12/30/2009	WO2009038770A3 Detoxified recombinant botulinum neurotoxin
12/30/2009	WO2009032949A3 High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
12/30/2009	WO2009005973A3 Synthetic gene for enhanced expression in e.coli
12/30/2009	WO2008131215A3 Engineered phosphite dehydrogenase mutants
12/30/2009	WO2008118487A3 Compositions and methods for incresing immunogenicity of glycoprotein vaccines
12/30/2009	WO2005040229A3 Ldl receptor class a and egf domain monomers and multimers
12/30/2009	EP2138582A2 DNA and specific peptides or proteins of bacteria of the species neisseria meningitidis, methods for obtaining same and their biological applications
12/30/2009	EP2138510A1 Methods of generating antibodies against cytokines
12/30/2009	EP2138458A1 High throughput discovery of materials through vapor phase synthesis
12/30/2009	EP2137320A1 High expression clones of mammalian cells with fluorescent protein a or g
12/30/2009	EP2137305A1 Engineered versions of cgtb (beta-1,3- galactosyltransferase) enzymes, with enhanced enzymatic properties
12/30/2009	EP2137292A1 Peptide mixture as wine stabiliser
12/30/2009	EP2137212A2 Mannoprotein liquid formulations
12/30/2009	EP1438325B1 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
12/30/2009	EP1117774B1 Method for generating diversity
12/30/2009	EP0804561B1 Regulated transcription of targeted genes and other biological events
12/30/2009	EP0791058B1 Use of a nucleotide sequence encoding the enzyme i-scei
12/30/2009	CN101613735A Method for preparing organic polypeptide
12/30/2009	CN101613734A Method for preparing plasma polypeptide
12/30/2009	CN101613733A Method for preparing feather polypeptide
12/30/2009	CN101613732A Recycling technology of leftovers of crawfish
12/30/2009	CN101613731A Recycling technology of leftovers of ictalurus punctatus
12/30/2009	CN101613718A Genetically engineered duckweed
12/30/2009	CN101613705A Optimizing glycan processing in plants
12/30/2009	CN100575493C Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
12/30/2009	CN100575488C Method for expressing metallothionein of human by using body of vegetable oil
12/30/2009	CN100575482C Novel cytokine zcytor17 ligand
12/30/2009	CN100575363C Human source anti-A botulinum neurotoxin genetic engineering antibody and preparation method and use thereof
12/30/2009	CA2729375A1 Improved protein production and storage in plants
12/30/2009	CA2728734A1 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof
12/29/2009	US7638619 Nucleotide sequences coding hepatocyte specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents
12/29/2009	US7638618 Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
12/29/2009	US7638607 Urocortin proteins and uses thereof
12/29/2009	US7638605 Fully human antibodies directed against the human insulin-like growth factor-1 receptor
12/29/2009	US7638604 Monoclonal antibodies against interleukin-22
12/29/2009	US7638603 Use in diagnosis and treatment of cytokine disorders such as tumor metastasis, angiogenesis, cellular migration and ovulation, as well as neurogenesis
12/29/2009	US7638602 Heterodimeric human cytokine receptor comprising Zcytor16/Zcytor11 components for use in treatment of cell proliferative, inflammatory and immune disorders
12/29/2009	US7638331 chimeric gene construct composed of a COX-2 promoter operably linked to at least one apoptosis-inducing gene that can cause selectively induced apoptosis in a population of diseased cells; entire classes of cells can be treated with one transfection
12/29/2009	US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/29/2009	US7638323 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering
12/29/2009	US7638305 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing
12/29/2009	US7638304 Hybrid fusion protein transcription regulator to induce interferon target gene expression
12/29/2009	US7638303 Soluble ErbB3 receptor isoforms
12/29/2009	US7638302 Soluble ErbB3 receptor isoforms
12/29/2009	US7638301 Prodomain modulators of ADAM 10
12/29/2009	US7638300 In vivo incorporation of unnatural amino acids
12/29/2009	US7638299 Biosynthetic polypeptides utilizing non-naturally encoded amino acids
12/29/2009	US7638297 Compositions for protein biosynthetic machinery; orthogonal lysyl-tRNAs, orthogonal lysyl-aminoacyl-tRNA synthetases and orthogonal pairs of lysyl-tRNAs/synthetases which incorporate homoglutamines into proteins are provided in response to four base codon; biosynthesis enzyme; therapeutic use
12/29/2009	US7638296 culturing in a medium containing insulin; use in the treatment of anemia; industrial scale production; high quality, purity
12/29/2009	US7638281 Polypeptide, cDNA encoding the same and use of them
12/29/2009	US7638269 Viral capsid assembly intermediates and methods of production
12/29/2009	US7638136 fusion proteins; encode hyperimmune serum reactive antigen or fragment thereof; immunogens
12/29/2009	US7638131 Coccidiosis poultry vaccine
12/29/2009	US7638129 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
12/29/2009	US7638125 different epitopes are located within the binding domain of the natural ligand(s) of said receptor; first and second antigen-binding site binds to a different epitope on the same EGFR molecule; anticarcinogenicb antimetastasis agents
12/29/2009	US7638124 Antigen-presenting complex-binding compositions and uses thereof

1 ... 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 ... 1125